
Cancer Screening Rates in Alberta
Oncology (Cancer Care)
2022-11-15 – Present
Early cancer detection is the cornerstone of improved survival rates and successful treatment outcomes. Alberta’s Screening for Life Program provides essential early detection for breast, cervical, and colorectal cancers across key age demographics. However, the onset of the COVID-19 pandemic necessitated a total suspension of these provincial programs from March to May 2020, followed by over two years of intermittent public health restrictions. This unprecedented disruption led to a significant decline in screening rates and new diagnoses, creating a critical screening gap that persisted well into the recovery period.
This project, led by Dr. Finlay McAlister, aims to quantify the long-term impact of these disruptions by conducting a comprehensive assessment of Alberta’s cancer screening trajectories. A primary focus of the study is the integration of 2021 Canada Census socioeconomic indicators, allowing the team to explore how factors such as income, geography, and primary care access influenced screening utilization during and after the pandemic. By evaluating adherence to provincial screening recommendations across diverse populations, the project provides the clinical intelligence necessary to help drive targeted recovery efforts. The insights generated from this work are essential for identifying vulnerable populations that may have been disproportionately affected by the pandemic.
These findings will provide critical baseline data to identify where screening gaps are most pronounced across Alberta — informing targeted knowledge translation activities and quality improvement efforts to support equitable access to cancer screening and reduce the long-term burden of late-stage cancer diagnoses.